Patents by Inventor Todd J. Sheldon

Todd J. Sheldon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11123005
    Abstract: An implantable medical device is configured to determine a first atrial arrhythmia score from ventricular events sensed by a sensing circuit of an implantable medical device and determine a second atrial arrhythmia score from an intraventricular signal comprising atrial mechanical event signals attendant to atrial systole and produced by a sensor of the implantable medical device. An atrial arrhythmia is detected based on the first atrial arrhythmia score and the second atrial arrhythmia score.
    Type: Grant
    Filed: November 12, 2018
    Date of Patent: September 21, 2021
    Assignee: Medtronic, Inc
    Inventors: Shantanu Sarkar, Wade M. Demmer, Todd J. Sheldon, Vincent E. Splett
  • Publication number: 20210283402
    Abstract: An implantable medical device system receives a cardiac electrical signal produced by a patient's heart and comprising atrial P-waves and delivers a His bundle pacing pulse to the patient's heart via a His pacing electrode vector. The system determines a timing of a sensed atrial P-wave relative to the His bundle pacing pulse and determines a type of capture of the His bundle pacing pulse in response to the determined timing of the atrial P-wave.
    Type: Application
    Filed: May 17, 2021
    Publication date: September 16, 2021
    Inventors: Todd J. SHELDON, Elizabeth A. MATTSON, Eric R. WILLIAMS
  • Patent number: 11103186
    Abstract: An implantable medical device system includes a pacemaker and an implantable cardioverter defibrillator (ICD). The pacemaker is configured to confirm a hemodynamically unstable rhythm based on an activity metric determined from an activity sensor signal after detecting a ventricular tachyarrhythmia and withhold anti-tachycardia pacing (ATP) pulses in response to confirming the hemodynamically unstable rhythm. The pacemaker may deliver ATP when a hemodynamically unstable rhythm is not confirmed based on the activity metric. The ICD is configured to detect the ATP and withhold a shock therapy in response to detecting the ATP in some examples.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: August 31, 2021
    Assignee: Medtronic, Inc.
    Inventors: Todd J. Sheldon, Wade M. Demmer, Teresa A. Whitman
  • Publication number: 20210236825
    Abstract: A medical device includes a motion sensor configured to produce a motion signal and a control circuit configured to set sensing control parameters and sense atrial events from the motion signal during ventricular cycles according to the sensing control parameters. In some examples, the control circuit is configured to determine a feature of the motion signal for at least some ventricular cycles, determine a metric of the motion signal based on the determined features, and adjust at least one of the sensing control parameters based on the metric.
    Type: Application
    Filed: January 27, 2021
    Publication date: August 5, 2021
    Inventors: Todd J. SHELDON, Keelia M. Escalante, Greggory R. HERR, Juliana E. PRONOVICI, Vincent E. SPLETT
  • Publication number: 20210236828
    Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.
    Type: Application
    Filed: April 19, 2021
    Publication date: August 5, 2021
    Inventors: Hyun J. Yoon, Wade M. Demmer, Matthew J. Hoffman, Robert A. Betzold, Jonathan D. Edmonson, Michael L. Ellingson, Ben W. Herberg, Juliana E. Pronovici, James D. Reinke, Todd J. Sheldon, Paul R. Solheim
  • Publication number: 20210236826
    Abstract: A medical device includes a motion sensor configured to produce a motion signal and a control circuit configured to sense atrial events from the motion signal. In some examples, the control circuit is configured to set a ventricular diastolic event window and set a threshold amplitude during the ventricular diastolic event window for sensing an atrial event in response to the motion signal crossing the threshold amplitude during the ventricular diastolic window. The control circuit may determine a maximum amplitude of the motion signal during the ventricular diastolic event window for multiple ventricular cycles and determine an amplitude metric based on at least a portion of the determined maximum amplitudes. The control circuit may determine a target value of the threshold amplitude based on at least the amplitude metric and adjust the threshold amplitude toward the target value.
    Type: Application
    Filed: January 27, 2021
    Publication date: August 5, 2021
    Inventors: Todd J. SHELDON, Paul R. SOLHEIM, Vincent E. SPLETT
  • Patent number: 11077307
    Abstract: An intracardiac pacemaker system is configured to produce physiological atrial event signals by a sensing circuit of a ventricular intracardiac pacemaker and select a first atrial event input as the physiological atrial event signals. The ventricular intracardiac pacemaker detects atrial events from the selected first atrial event input, determines if input switching criteria are met, and switches from the first atrial event input to a second atrial event input in response to the input switching criteria being met. The second atrial event input includes broadcast atrial event signals produced by a second implantable medical device and received by the ventricular intracardiac pacemaker.
    Type: Grant
    Filed: June 24, 2019
    Date of Patent: August 3, 2021
    Assignee: Medtronic, Inc.
    Inventors: Wade M. Demmer, Yong K. Cho, Mark K. Erickson, Todd J. Sheldon
  • Patent number: 11007369
    Abstract: An implantable medical device system receives a cardiac electrical signal produced by a patient's heart and comprising atrial P-waves and delivers a His bundle pacing pulse to the patient's heart via a His pacing electrode vector. The system determines a timing of a sensed atrial P-wave relative to the His bundle pacing pulse and determines a type of capture of the His bundle pacing pulse in response to the determined timing of the atrial P-wave.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: May 18, 2021
    Assignee: Medtronic, Inc.
    Inventors: Todd J. Sheldon, Elizabeth A. Mattson, Eric R. Williams
  • Patent number: 10981010
    Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.
    Type: Grant
    Filed: May 13, 2019
    Date of Patent: April 20, 2021
    Assignee: Medtronic, Inc.
    Inventors: Hyun J. Yoon, Wade M. Demmer, Matthew J. Hoffman, Robert A. Betzold, Jonathan D. Edmonson, Michael L. Ellingson, Ben W. Herberg, Juliana E. Pronovici, James D. Reinke, Todd J. Sheldon, Paul R. Solheim
  • Publication number: 20210077815
    Abstract: An intracardiac ventricular pacemaker is configured to operate in in a selected one of an atrial-tracking ventricular pacing mode and a non-atrial tracking ventricular pacing mode. A control circuit of the pacemaker determines at least one motion signal metric from the motion signal, compares the at least one motion signal metric to pacing mode switching criteria, and, responsive to the pacing mode switching criteria being satisfied, switches from the selected one of the non-atrial tracking pacing mode and the atrial tracking pacing mode to the other one of the non-atrial tracking pacing mode and the atrial tracking pacing mode for controlling ventricular pacing pulses delivered by the pacemaker.
    Type: Application
    Filed: November 30, 2020
    Publication date: March 18, 2021
    Inventors: Todd J. SHELDON, Yong K. CHO, Wade M. DEMMER, Mark K. ERICKSON, Vincent E. SPLETT
  • Publication number: 20210052895
    Abstract: A medical device is configured to set a post-atrial time interval in response to an atrial event and generate an event time signal in response to a ventricular electrical signal crossing an R-wave sensing threshold during the post-atrial time interval. The device accumulates oversensing evidence in response to the event time signal and adjusts a ventricular sensing control parameter based on the accumulated oversensing evidence in some examples.
    Type: Application
    Filed: August 18, 2020
    Publication date: February 25, 2021
    Inventors: Maureen E. LYBARGER, Jian CAO, Wade M. DEMMER, Michael W. HEINKS, Jean E. HUDSON, Michael KEMMERER, James J. ST. MARTIN, Todd J. SHELDON
  • Publication number: 20200406041
    Abstract: A medical device is configured to sense a cardiac electrical signal and determine from the cardiac electrical signal at least one of a maximum peak amplitude of a positive slope of the cardiac electrical signal and a maximum peak time interval from a pacing pulse to the maximum peak amplitude. The device is configured to determine a capture type of the pacing pulse based on at least one or both of the maximum peak amplitude and the maximum peak time interval.
    Type: Application
    Filed: June 15, 2020
    Publication date: December 31, 2020
    Inventors: Jian CAO, Wade M. DEMMER, Maureen E. LYBARGER, Elizabeth A. MATTSON, Todd J. SHELDON, Zhongping YANG, Xiaohong ZHOU
  • Patent number: 10864377
    Abstract: An intracardiac ventricular pacemaker is configured to operate in in a selected one of an atrial-tracking ventricular pacing mode and a non-atrial tracking ventricular pacing mode. A control circuit of the pacemaker determines at least one motion signal metric from the motion signal, compares the at least one motion signal metric to pacing mode switching criteria, and, responsive to the pacing mode switching criteria being satisfied, switches from the selected one of the non-atrial tracking pacing mode and the atrial tracking pacing mode to the other one of the non-atrial tracking pacing mode and the atrial tracking pacing mode for controlling ventricular pacing pulses delivered by the pacemaker.
    Type: Grant
    Filed: June 28, 2018
    Date of Patent: December 15, 2020
    Assignee: Medtronic, Inc.
    Inventors: Todd J. Sheldon, Yong K. Cho, Wade M. Demmer, Mark K. Erickson, Vincent E. Splett
  • Publication number: 20200368540
    Abstract: Techniques for minimizing rate of depletion of a non-rechargeable power source, to extend the operational lifetime of an implantable medical device that includes the non-rechargeable power source, by enforcing operational-mode-specific communication protocols whereby inter-device communication between the implantable medical device and another implantable medical device is such that level of power draw from the non-rechargeable power source by the implantable medical device is less than level of power draw from the rechargeable power source by the another implantable medical device for the implantable medical devices to engage in communication with each other.
    Type: Application
    Filed: August 11, 2020
    Publication date: November 26, 2020
    Inventors: Wade M. Demmer, Yong K. Cho, Michael F. Hess, Todd J. Sheldon
  • Publication number: 20200368535
    Abstract: A pacemaker having a motion sensor delivers atrial-synchronized ventricular pacing by detecting events from a signal produced by the motion sensor and delivering ventricular pacing pulses at a rate that tracks the rate of the detected events. The pacemaker is configured to confirm atrial tracking of the ventricular pacing pulses by determining if detected events from the motion sensor signal are atrial events. The pacemaker is configured to adjust a control parameter used for detecting events from the motion sensor signal if atrial tracking is not confirmed.
    Type: Application
    Filed: August 14, 2020
    Publication date: November 26, 2020
    Inventors: Todd J. SHELDON, Wade M. DEMMER, Greggory R. HERR
  • Publication number: 20200316386
    Abstract: A medical device includes a motion sensor for producing a motion signal including cardiac event signals. The medical device generates a ventricular pacing pulse upon expiration of a pacing interval. The medical device determines a synchrony metric from the motion signal after a delivered ventricular pacing pulse and adjusts the pacing interval based on the synchrony metric.
    Type: Application
    Filed: March 30, 2020
    Publication date: October 8, 2020
    Inventors: Wade M. DEMMER, Alexander R. MATTSON, Todd J. SHELDON, Zhongping YANG
  • Publication number: 20200289821
    Abstract: A leadless pacing system includes a leadless pacing device and a sensing extension extending from a housing of the leadless pacing device. The sensing extension includes one or more electrodes with which the leadless pacing device may sense electrical cardiac activity. The one or more electrodes of the sensing extension may be carried by a self-supporting body that is configured to passively position the one or more electrodes proximate or within a chamber of the heart other than the chamber in which the LPD is implanted.
    Type: Application
    Filed: June 3, 2020
    Publication date: September 17, 2020
    Inventors: Thomas A. ANDERSON, Todd J. SHELDON, Matthew D. BONNER, Noelle C. NEAFUS
  • Patent number: 10773086
    Abstract: An IMD system receives a near field His bundle electrical signal produced by a patient's heart via a first sensing electrode vector and a far field cardiac electrical signal via a second sensing electrode vector different than the first sensing electrode vector. The IMD system generates His bundle pacing pulses delivered to the patient's heart via a His pacing electrode vector and determines a type of cardiac capture evoked by a His bundle pacing pulse.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: September 15, 2020
    Assignee: Medtronic, Inc.
    Inventors: Todd J. Sheldon, Shawn M. Campbell, Maureen E. Lybarger, Elizabeth A. Mattson, Eric R. Williams, Zhongping Yang
  • Patent number: 10751542
    Abstract: Techniques for minimizing rate of depletion of a non-rechargeable power source, to extend the operational lifetime of an implantable medical device that includes the non-rechargeable power source, by enforcing operational-mode-specific communication protocols whereby inter-device communication between the implantable medical device and another implantable medical device is such that level of power draw from the non-rechargeable power source by the implantable medical device is less than level of power draw from the rechargeable power source by the another implantable medical device for the implantable medical devices to engage in communication with each other.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: August 25, 2020
    Assignee: Medtronic, Inc.
    Inventors: Wade M. Demmer, Yong K. Cho, Michael F. Hess, Todd J. Sheldon
  • Patent number: RE48197
    Abstract: A leadless pacing device (LPD) includes a motion sensor configured to generate a motion signal as a function of heart movement. The LPD is configured to analyze the motion signal within an atrial contraction detection window that begins an atrial contraction detection delay period after activation of the ventricle, and detect a contraction of an atrium of the heart based on the analysis of the motion signal within the atrial contraction detection window. If the LPD does not detect a ventricular depolarization subsequent to the atrial contraction, e.g., with an atrio-ventricular (AV) interval beginning when the atrial contraction was detected, the LPD delivers a ventricular pacing pulse.
    Type: Grant
    Filed: July 25, 2018
    Date of Patent: September 8, 2020
    Assignee: Medtronic, Inc.
    Inventors: Yong K. Cho, Aleksandre T. Sambelashvili, Todd J. Sheldon